[Asia Economy Reporter Park Jihwan] Daewoong announced on the 14th that its subsidiary Daewoong Pharmaceutical has signed a supply contract for the export of Fexuprazan to Brazil worth 85.9 billion KRW. This corresponds to 7.72% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
